Skip to main content

7 Result(s)

within Hyeong Dong Yuk Remove this filter Medicine & Public Health Remove this filter

and

  1. No Access

    Article

    Tubular damage marker as a predictive factor for pathologically upstaged renal cell carcinoma

    To investigate if increased tubular damage biomarker can predict pathologically upstaged renal cell carcinoma (RCC), which may possess sub-radiologic invasive behavior, leading to surrounding tubular damage.

    Jang Hee Han, Seung-hwan Jeong, Si Hyun Kim, Gyeong Hun Kim… in World Journal of Urology (2023)

  2. Article

    Open Access

    Clinical features and Surgical Outcome of Clear Cell Papillary Renal Cell Tumor: result from a prospective cohort

    Clear cell papillary renal cell tumor (CCPRCT) was first reported in 2006 a patient with end stage renal disease. After that it was discovered in the kidney without end stage renal disease in the 2010s and sta...

    Si Hyun Kim, Jang Hee Han, Seung-hwan Jeong, Hyeong Dong Yuk, Ja Hyeon Ku… in BMC Urology (2023)

    Download PDF (698 KB) View Article

  3. Article

    Open Access

    The effect of preoperative ureteral stenting in retrograde Intrarenal surgery: a multicenter, propensity score-matched study

    Stent placement before retrograde intrarenal surgery (RIRS) can theoretically expand the ureter to improve access and remove stones. The purpose of this study was to investigate the effect of preoperative uret...

    Hyeong Dong Yuk, Juhyun Park, Sung Yong Cho, Luck Hee Sung, Chang Wook Jeong in BMC Urology (2020)

    Download PDF (512 KB) View Article

  4. No Access

    Chapter

    Multimodality Therapy

    Trimodality therapy (TMT) for localized muscle-invasive bladder cancer (MIBC) is a substitute for radical cystectomy. TMT consists of chemoradiation and transurethral resection of bladder tumor (TURB). The pur...

    Jung Hoon Lee, Jae Hyun Jung, Hyeong Dong Yuk in Management of Urothelial Carcinoma (2019)

  5. No Access

    Chapter

    Radical Cystectomy

    Bladder cancer is the fourth most common cancer in men in the United States. About 60,000 people develop each year. Bladder cancer is the eighth leading cause of cancer deaths in the United States. About 12,00...

    Hyeong Dong Yuk in Management of Urothelial Carcinoma (2019)

  6. No Access

    Chapter

    Treatment of Metastatic Bladder Cancer

    Most bladder cancer patients present with noninvasive bladder cancer, but 20–40% of patients progress to advanced state with muscle-invasive or metastatic disease (Raghavan, Urol Oncol 21:468–474, 2003). In ge...

    Won Hoon Song, Hyeong Dong Yuk in Management of Urothelial Carcinoma (2019)

  7. No Access

    Chapter

    Role of Radical Prostatectomy in the Management of Metastatic Prostate Cancer

    Most of prostate cancers diagnosed at localized disease were regarded as less aggressive malignancy because of their indolent course; nonetheless, metastatic prostate cancer is still lethal. The 5-year surviva...

    Hyeong Dong Yuk, Cheol Kwak in Management of Advanced Prostate Cancer (2018)